Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma
ClinicalTrials.gov study NCT05085444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
ClinicalTrials.gov study NCT04995003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
ClinicalTrials.gov study NCT06006390. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas
ClinicalTrials.gov study NCT04952584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
ClinicalTrials.gov study NCT06945523. IPD Sharing: NO. Countries: 1. Publications: 0.
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
ClinicalTrials.gov study NCT05043571. IPD Sharing: NO. Countries: 1. Publications: 0.
Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies
ClinicalTrials.gov study NCT03624686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05326243. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04214886. IPD Sharing: NO. Countries: 1. Publications: 0.
CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT05143151. IPD Sharing: NO. Countries: 1. Publications: 0.
FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06609928. IPD Sharing: NO. Countries: 1. Publications: 0.
Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies
ClinicalTrials.gov study NCT04732845. IPD Sharing: YES. Countries: 1. Publications: 0.
Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05052528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome
ClinicalTrials.gov study NCT06967038. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor-Modified T Cells for Breast Cancer
ClinicalTrials.gov study NCT02547961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis
ClinicalTrials.gov study NCT05085418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
ClinicalTrials.gov study NCT06043466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
ClinicalTrials.gov study NCT06055439. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
ClinicalTrials.gov study NCT04214392. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT06420089. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.